Olmiwake-Trio Tablet

Olmiwake-Trio Tablet
Olmesartan Medoxomil (40mg) + Cilnidipine (10mg) + Chlorthalidone (12.5mg)
Cheaper alternative availability
Already at the Best Price
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
About This Medicine
Product description & overview
Olmiwake-Trio Tablet: A Comprehensive Solution for High Blood Pressure
Olmiwake-Trio Tablet is a convenient, once-daily combination medication designed to effectively manage hypertension (high blood pressure). This formulation combines the potent antihypertensive properties of Olmesartan Medoxomil (40mg), Cilnidipine (10mg), and Chlorthalidone (12.5mg) for comprehensive blood pressure control.
Olmesartan Medoxomil, a selective angiotensin II receptor blocker, effectively reduces the effects of stress hormones, promoting relaxation in blood vessels. Cilnidipine, a dihydropyridine calcium channel blocker, exerts its effect by inhibiting the influx of calcium into vascular smooth muscle cells, thereby relaxing and dilating blood vessels. Finally, Chlorthalidone acts as a diuretic, reducing fluid volume and ultimately lowering blood pressure.
Olmiwake-Trio Tablet ensures precise dosage management for optimal effectiveness and ease of use. This combination therapy offers a comprehensive approach to managing hypertension by targeting multiple pathways involved in blood pressure regulation.
Active composition
Olmesartan Medoxomil 40 mg
+2 more active ingredients
About Olmesartan Medoxomil
Olmesartan Medoxomil is an antihypertensive medication used to treat high blood pressure. It works by blocking angiotensin II receptors, leading to vasodilation and reduced blood pressure. Olmesartan Medoxomil is effective for managing hypertension. In summary, it is essential for cardiovascular health.
How It Works
Olmesartan Medoxomil blocks angiotensin II receptors, preventing vasoconstriction and lowering blood pressure.
All Active Ingredients
Cilnidipine
Cilnidipine inhibits L-type and N-type calcium channels in vascular smooth muscle, leading to vasodilation and reduced blood pressure.
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Side Effect Occurrence
Based on clinical trials and patient reports.
Overall Tolerance
Most patients tolerate well
Common Side Effects
Safety Advice
Alcohol
Olmiwake-Trio Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
High Risk
Pregnancy
Olmiwake-Trio Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
Driving
Olmiwake-Trio Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Olmiwake-Trio Tablet may be needed. Please consult your doctor. Use of Olmiwake-Trio Tablet is not recommended in these patients.
Exercise Caution
Breastfeeding
Olmiwake-Trio Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Consult Doctor
Kidney
Olmiwake-Trio Tablet should be used with caution in patients with liver disease. Dose adjustment of Olmiwake-Trio Tablet may be needed. Please consult your doctor. Use of Olmiwake-Trio Tablet is not recommended in patients with severe liver disease.
Regular Checkup
Customer Reviews
0 reviews for Olmiwake-Trio Tablet